Hemogenyx Pharmaceuticals Media (HEMO)
HEMO Share
HEMO Share
HEMO Share
HEMO Share
HEMO
HEMO Share
HEMO Level 2
HEMO Live
HEMO Broker
HEMO Directors
HEMO Financial
HEMO
HEMO Short
HEMO
HEMO Company
HEMO Company
Last checked at -
Hemogenyx Pharmaceuticals ( LSE:HEMO ) is progressing toward its first revenue opportunity foe CAR-T therapy for relapsed/refractory acute myeloid leukemia. CEO & Co-Founder, Vladislav S...
Which stocks are hot after Trump's second state visit and is the current US President angling for a 2028 constitutional crisis? Sarah talks tech, pharmaceutical, crypto and coronets. ...
What is a patent cliff and why is the pharmaceutical sector under the microscope, which new entrant makes mining safe and interesting and which route is being taken by car dealerships? Sarah ta...
As investors ask 'What day is it?' individual stock stories shine with proactive supply chain solutions from ASOS ( ASC ) and platforms for growth from Microlise ( SAAS ), Hemogenyx ( HEMO ) and two ...
Dr Vladislav Sandler, Co-Founder and CEO of HemoGenyx Pharmaceuticals #LSE #HEMO discusses two major announcements with London South East. First data results show that CDX antibodies have b...
#HEMO are a London-listed, US-based biotech company developing two revolutionary blood cancer treatments. CDX antibodies are intended to remove the need for chemo and radiation before a bone mar...
Sign In
Last checked at 
Follow the stocks
